Cardiology

• Meeting News Coverage

• Empagliflozin lowered systolic BP, regardless of weight, HbA1c

• Cardiology Today, November 2012
• Patients with type 2 diabetes experienced significant reductions in systolic blood pressure after treatment with empagliflozin that were independent of...More »

• Meeting News Coverage

• Diabetes increases death rate among U.K. youth

• Endocrine Today, November 2012
• Research presented at the 48th Annual Meeting of the European Association for the Study of Diabetes in Berlin demonstrates that women in the U.K. with...More »

• Meeting News Coverage

• President of EASD calls for improved device registration, monitoring in Europe

• October 4, 2012
• European diabetes device regulation is in need of “radical change,” according to president of the European Association for the Study of...More »

• Meeting News Coverage

• Four studies find linagliptin effective as monotherapy, add-on in adults with type 2 diabetes

• October 2, 2012
• Linagliptin administered alone or in combination with other diabetes medications, and as an add-on to basal insulin therapy, lowered HbA1c in elderly...More »

• CME

• Cardiovascular Consults: Volume 2, Number 1

• While metformin remains the mainstay of first-line pharmacotherapy for type 2 diabetes, clinical evidence does not yet support a clear line of succession for treatment subsequent to metformin…...More »
• This activity is supported by an educational grant from Amylin.

• In the Journals

• DPP-IV inhibitors appear to reduce CV risk in type 2 diabetes

• Cardiology Today, November 2012
• Unlike traditional oral diabetes medications, DDP-IV inhibitors have been associated with a decreased risk for cardiovascular events in patients with type...More »

• Meeting News Coverage Perspective

• Psoriasis appears to increase risk for diabetes

• August 30, 2012
• Patients with psoriasis appear to be at increased risk for developing new-onset diabetes, according to data presented at the European Society of...More »

• In the Journals

• CVD rates similar between patients with inflammatory arthritis, diabetes

• August 28, 2012
• Patients with inflammatory arthritis demonstrated a higher rate of cardiovascular disease compared with those with osteoarthritis and similar levels to...More »

• CME Video

• GLP-1 Agonists: Examining New Data on Cardiovascular Risk Reduction, Combination Insulin Therapy, and Adherence

• The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of benefits in patients with type 2 diabetes, including weight…...More »
• This activity is supported by an educational grant from Amylin.

• In the Journals

• TRIAD study: Diabetes complications, comorbidities linked to poorer quality of life

• Endocrine Today, September 2012
• After assessing health utility scores associated with type 2 diabetes, researchers found that major diabetes complications and comorbidities, such as...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!